German stock market: whose business has gained new momentum?
The German economic engine has slowly started to gather pace again after a winter standstill. In this overview, we bring you three companies on the Frankfurt Stock Exchange whose financial results for the first quarter of 2026 show the clearest acceleration in business activity. Although sportswear manufacturer Puma showed a net profit growth reaching thousands of percent on paper, we are leaving them out of the top three. Their result was not driven by real sales success, but by favorable exchange rates and one-off tax effects. Our focus is on companies whose growth is backed by a genuinely strengthening core business.
Bayer's operating profit made a remarkable turnaround in the first quarter, growing by 10.1% compared to the same period last year and reaching 3.2 billion euros. Although the company's total revenue still fell slightly, they managed to cut costs faster than revenues declined. In addition, the stock is supported by positive news from the US Food and Drug Administration (FDA), which granted Fast Track designation to their new kidney drug Kerendia, helping to alleviate concerns about the expiration of patents for older drugs.
The main engine of this strong result is Bayer's agricultural unit, where successful sales of soybean and corn seeds in North America, combined with lower production costs, boosted profitability. For investors, this shows that although the company's pharmaceutical business is under pressure due to tighter competition, a strong agricultural business and the faster market introduction of new drugs can successfully offset this weakness.
Reinsurer Hannover Re's operating profit made an extraordinary 39.4% jump, reaching 971 million euros. Although the company's sales revenue fell at the same time as several large contracts ended, operating costs were reduced at an even faster pace. This exceptional profit growth is also the reason why the company is on our list, despite the fact that the market has temporarily pushed the stock price down in fear of a decline in revenue and potential price pressure.
There is a very clear reason behind the profit jump: the company had to pay out much less in major loss claims than expected and was able to price its insurance risks better. This means that although the volume of contracts has slightly decreased, Hannover Re earns significantly more profit on each remaining contract. This shows strong discipline, where quality and profitability are preferred over simply chasing volume.
Automotive components manufacturer Continental managed to turn its operating profit back to a 6.1% growth, earning 522 million euros. This is particularly noteworthy because the company's revenue fell by more than a tenth at the same time. The market has warmly welcomed these results, as the profit exceeded analysts' expectations and the company confirmed its current economic forecasts, dispelling earlier fears regarding US tariffs and weakening demand.
The secret to Continental's success lies in a smart product range and strict cost control. The company has consciously focused on selling more expensive and higher-margin tires, which, together with cheaper raw materials, leaves more money in hand for every tire sold. This gives investors confidence that even if the global automotive industry is currently slowing down, Continental can protect its profit and manage efficiently.
Conclusion
These three major German companies clearly show that increasing sales volumes is not always necessary to grow profits. Bayer's successful agricultural business, Hannover Re's smart risk assessment, and Continental's focus on more expensive products prove that smart cost management and the right strategy yield results even in a more challenging market environment. In the coming months, it will be exciting to see whether these companies can maintain their new level of efficiency even if the general economic environment should change.
RYTM content is for informational purposes only, not financial advice or recommendations. You are solely responsible for your investment decisions. Always consult a professional.